Antigens, CD - Metabolism
Research News and Information

Saturday, November 21, 2009

Runx2, p53, and pRB status as diagnostic parameters for deregulation of osteoblast growth and differentiation in a new pre-chemotherapeutic osteosarcoma cell line (OS1).

29 Nov 2009 Osteosarcomas are the most prevalent primary bone tumors found in pediatric patients. To understand their molecular etiology, cell culture models are used to define disease mechanisms under controlled conditions. Many osteosarcoma cell lines (e.g., ... Read more...

Molecular mechanisms mediating protective effect of cAMP on lipopolysaccharide (LPS)-induced human lung microvascular endothelial cells (HLMVEC) hyperpermeability.

29 Nov 2009 Up to date, the nature of the sepsis-induced vascular leakage is understood only partially, which limits pharmacological approaches for its management. Here we studied the protective effect of cAMP using endotoxin-induced hyperpermeability as a ... Read more...

Intracellular presence of insulin and its phosphorylated receptor in non-small cell lung cancer.

29 Nov 2009 Insulin has been known for a long time to influence the growth and differentiation of normal and transformed cells. In order to delineate the role of insulin specifically in non-small cell lung cancer (NSCLC), we have now searched by ... Read more...

Latest indexed articles for 'Antigens, CD - Metabolism'

These are the very latest articles for this heading:

• Runx2, p53, and pRB status as diagnostic parameters for deregulation of osteoblast growth and differentiation in a new pre-chemotherapeutic osteosarcoma cell line (OS1). 29 Nov 2009
• Molecular mechanisms mediating protective effect of cAMP on lipopolysaccharide (LPS)-induced human lung microvascular endothelial cells (HLMVEC) hyperpermeability. 29 Nov 2009
• Intracellular presence of insulin and its phosphorylated receptor in non-small cell lung cancer. 29 Nov 2009
• Interaction of B7-H1 on intrahepatic cholangiocarcinoma cells with PD-1 on tumor-infiltrating T cells as a mechanism of immune evasion. 30 Oct 2009
• Enhanced MDR1 expression and chemoresistance of cancer stem cells derived from glioblastoma. 30 Oct 2009
• Existence of exocytotic hemifusion intermediates with a lifetime of up to seconds in type II pneumocytes. 21 Oct 2009
• Primary human tumor cells expressing CD155 impair tumor targeting by down-regulating DNAM-1 on NK cells. 13 Oct 2009
• Expression of the macrophage antigen CD163 in rectal cancer cells is associated with early local recurrence and reduced survival time. 13 Oct 2009
• The hepatitis C virus and its hepatic environment: a toxic but finely tuned partnership. 10 Oct 2009
• Allogeneic induced human FOXP3(+)IFN-gamma(+) T cells exhibit selective suppressive capacity. 29 Sep 2009
• Effect of CD133/prominin-1 antisense oligodeoxynucleotide on in vitro growth characteristics of Huh-7 human hepatocarcinoma cells and U251 human glioma cells. 29 Sep 2009
• A novel nonsynonymous variant of matrix metalloproteinase-7 confers risk of liver cirrhosis. 29 Sep 2009
• Modulation of invasive properties of CD133+ glioblastoma stem cells: a role for MT1-MMP in bioactive lysophospholipid signaling. 29 Sep 2009
• IGF-1 released by corneal epithelial cells induces up-regulation of N-cadherin in corneal fibroblasts. 29 Sep 2009
• Costimulatory pathways in multiple sclerosis: distinctive expression of PD-1 and PD-L1 in patients with different patterns of disease. 28 Sep 2009
• Essential roles for Dok2 and RasGAP in CD200 receptor-mediated regulation of human myeloid cells. 26 Sep 2009
• Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal. 25 Sep 2009
• Genetic evidence that the differential expression of the ligand-independent isoform of CTLA-4 is the molecular basis of the Idd5.1 type 1 diabetes region in nonobese diabetic mice. 23 Sep 2009
• T lineage differentiation from induced pluripotent stem cells. 13 Sep 2009
• Determination of hepatitis C virus-infected, monocyte lineage reservoirs in individuals with or without HIV coinfection. 13 Sep 2009

See a longer list of these articles.

Technical information about 'Antigens, CD'

Definition: Differentiation antigens residing on mammalian leukocytes. CD stands for cluster of differentiation, which refers to groups of monoclonal antibodies that show similar reactivity with certain subpopulations of antigens of a particular lineage or differentiation stage. The subpopulations of antigens are also known by the same CD designation.

Registry Number: 0

Descriptor UI: D015703

Alternative terms: Antigens, CD; CD Antigens; Leukocyte Differentiation Antigens, Human; Differentiation Antigens, Leukocyte, Human;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; biosynthesis; blood; cerebrospinal fluid; classification; diagnostic use; drug effects; economics; genetics; history; immunology; isolation & purification; metabolism; pharmacology; physiology; poisoning; radiation effects; therapeutic use; toxicity; ultrastructure; urine; chemistry; contraindications;

Tree Number: D23.050.301.264.035; D23.101.100.110;

History Note: 90